Search

Headquarters

Contact Us

  • (+01) 512 835 8026
  • info@myriadrbm.com
  • 3300 Duval Road
    Austin, TX 78759
    USA
  • Mon to Fri - 8:50am to 5:00pm

Ready to order?

Great! Every order starts with a quote.

Get Started

  • (+01) 512 835 8026
  • info@myriadrbm.com
Get a Quote | Contact | FAQ's | Blog
Myriad RBM Myriad RBM

Innovative Biomarker Solutions

Toggle menu

Skip to content
  • About Us

    • About Myriad RBM

      Myriad RBM’s CLIA certified biomarker testing laboratory, is located in Austin, TX. Myriad RBM is a wholly owned subsidiary of Myriad Genetics, Inc. (MYGN), a leading molecular diagnostic company based in Salt Lake City, Utah which develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests.

    • About Myriad RBM

      • Overview
      • Management
      • Quality Policy
      • Employment
      • Partners
      • Sales Team
      • Certifications

    • Newsroom

      • Press
      • Company Newsletters
      • Conferences
      • Abstracts + Papers
      • Sign Up for Our Newsletter
      • Blog

    • Data Quality

      • Overview
      • Myriad RBM Technology
  • Biomarker Solutions

    • Solutions

      • Overview
      • Assay Change Log

      CustomMAP

      If a smaller, more focused panel of analytes is required, we can build a Custom MAP to meet your needs.

      Build Your CustomMAP »

    • Multiplexed Immunoassays

      • Full Biomarker Menu
      • DiscoveryMAP® v. 3.3
      • ExplorerMAP™ v. 1.0
      • HumanMAP® v. 2.0
      • CardiovascularMAP® v. 3.0
      • AngiogenesisMAP® v. 1.0
      • InflammationMAP® v. 1.0
      • ImmunoMAP® v. 1.0
      • NeuroMAP™ v. 1.0
      • MetabolicMAP® v. 1.0
      • KidneyMAP®
      • CytokineMAP A
      • CytokineMAP B
    • TruCulture

      Whole Blood Collection and Culture System

      Learn More »
      Quanterix simoa

      Ultrasensitive immunoassays manufactured by Myriad RBM and based on Quanterix’s Simoa technology.

      Learn More »
      Vectra DA

      The only validated multibiomarker blood test to measure rheumatoid arthritis (RA) disease activity.

      Learn More »
  • Resources + Support

    • Resources

      • Bibliography
      • White Papers
      • Events
      • Webinars
      • Blog

    • Support

      • Client Services
      • Request a Biomarker
      • Speak to a Scientist
  • How to Order

    • Ordering Information

      • Overview
      • Request a quote
      • Acceptable Samples
      • Frequently Asked Questions

    • Request Information

      • Contact Client Services
      • Request a Biomarker
      • Speak to a Scientist

    • Ready to Order?

      Great!

      Every order starts with a quote.

      Get Started

  •  

Category Archives: Blog

16 Jul 2018

Cereblon modulator iberdomide induces degradation of the transcription factors Ikaros and Aiolos: immunomodulation in healthy volunteers and relevance to systemic lupus erythematosus

July 16, 2018
myriadrbm
Autoimmune and Arthritis, Cytokines and Chemokines, Inflammation
Peter H. Schafer, Ying Ye, Lei Wu, Jolanta Kosek, Garth Ringheim, Zhihong Yang, Liangang Liu, Michael Thomas, Maria Palmisano, Rajesh Chopra Read Ful...
Read More
11 Jul 2018

Networks of blood proteins in the neuroimmunology of schizophrenia

July 11, 2018
myriadrbm
Cytokines and Chemokines, Inflammation, Neuroscience and Neurological
Clark D. Jeffries, Diana O. Perkins, Margot Fournier, Kim Q. Do, Michel Cuenod, Ines Khadimallah, Enrico Domenici, Jean Addington, Carrie E. Bearden,...
Read More
28 Jun 2018

IL-17 blockade with secukinumab in peripheral spondyloarthritis impacts synovial immunopathology without compromising systemic immune responses

June 28, 2018
myriadrbm
Autoimmune and Arthritis, Cytokines and Chemokines, Inflammation
Leonieke J.J. van Mens, Marleen G.H. van de Sande, Silvia Menegatti, Sija Chen, Iris C.J. Blijdorp, Henriette M. de Jong, Inka A. Fluri, Talia E. Latu...
Read More
13 Jun 2018

Association between IL-6 production in synovial explants from rheumatoid arthritis patients and clinical and imaging response to biologic treatment: A pilot study

June 13, 2018
myriadrbm
Autoimmune and Arthritis, Cytokines and Chemokines, Inflammation
Martin Andersen, Mikael Boesen, Karen Ellegaard, Kalle Söderström, Niels H. Søe, Pieter Spee, Ulrik G. W. Mørch, Søren Torp-Pedersen, Else M. Bartels,...
Read More
30 May 2018

Carbon nanotubes and nanofibers exposure and sputum and blood biomarkers of early effect among U.S. workers

May 30, 2018
myriadrbm
Cytokines and Chemokines, Inflammation
Carbon nanotubes and nanofibers are used in many fields, such as in manufacturing and information technology. Both of these carbon particles are physi...
Read More
8 May 2018

Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS

May 8, 2018
myriadrbm
Autoimmune and Arthritis
Nirupama Putcha, Gabriel G. Paul, Antoine Azar, Robert A. Wise, Wanda K. O’Neal, Mark T. Dransfield, Prescott G. Woodruff, Jeffrey L. Curtis, Alejandr...
Read More
23 Apr 2018

S100A12 and S100A8/9 Proteins are Biomarkers of Articular Disease Activity in Blau Syndrome

April 23, 2018
myriadrbm
Autoimmune and Arthritis, Cytokines and Chemokines, Inflammation
Lin Wang, Carlos D. Rosé, Kevin P. Foley, Jordi Anton, Brigitte Bader-Meunier, Philippe Brissaud, Gaelle Chédeville, Rolando Cimaz, Jorge Fernández-Ma...
Read More
1 2 3 4 … 19

Categories

  • Blog (128)
    • Autoimmune and Arthritis (10)
    • Cancer (28)
    • Cardiac (9)
    • Cytokines and Chemokines (21)
    • Diabetes (6)
    • Gastrointestinal (1)
    • Inflammation (42)
    • Neuroscience and Neurological (32)
    • News From the Lab (1)
    • Renal Function and Toxicity (7)
    • Technology- Multi-Analyte Profile (1)
  • Press (37)
  • Utilized Myriad RBM's Services (40)

ABOUT MYRIAD RBM

Overview
Management
Quality Policy
Employment
Partners
Sales Team
Certifications

NEWSLETTERS

Sign up to receive emails from Myriad RBM


MAPs

Full Biomarker Menu
DiscoveryMAP® v. 3.3
ExplorerMAP™ v. 1.0
HumanMAP® v. 2.0
CardiovascularMAP® v. 3.0
AngiogenesisMAP® v. 1.0
InflammationMAP® v. 1.0
ImmunoMAP® v. 1.0
NeuroMAP™ v. 1.0
MetabolicMAP® v. 1.0
KidneyMAP®
CytokineMAP A
CytokineMAP B

RESOURCES

Bibliography
White Papers
Events
Webinars
Blog

SUPPORT

Customer Support
Speak to a Scientist
Assay Change Log
FAQs
Request a Biomarker

SOLUTIONS

Results Processing
Assay Development
Quality Control
Project Management

SERVICES

Multiplexed Assay Services
Ultrasensitive Assays
TruCulture
VectraDA

  • Jobs
  • Terms of Use
  • Privacy Practice
  • Analytes Listing
Copyright © 2020 Myriad RBM. All rights reserved.